Security key
G2161P132
CHINA SXT PHARMACEUTICALS IN - SHS NEW (SXTC)
CUSIP: G2161P132
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / SHS NEW
- Total 13F shares
- 146,558
- Total 13F value
- $32,281
- Share change
- -90,269
- SEC-reported price per share
- $0.23
- Number of holders
- 4
- Value change
- -$24,023
- Number of buys
- 2
- Number of sells
- 4
Report period
Q2 2023
Institutions
4
Top holders
4
SXTC full security history
Ownership snapshot
Full 13F holder table
China SXT Pharmaceuticals, Inc. SEC filings
China SXT Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SXTC - CHINA SXT PHARMACEUTICALS IN - SHS NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ACADIAN ASSET MANAGEMENT LLC
Disclosed value leader
ACADIAN ASSET MANAGEMENT LLC
Comparable rows
0/7
Latest evidence
31 Mar 2023
13F
3/4/5
Highest disclosed value: $28,000
7 rows are not safely comparable across share classes.
Showing 1-6 of 7 holder rows.
Quick read
ACADIAN ASSET MANAGEMENT LLC has the largest disclosed position value at $28K.
0 of 7 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ACADIAN ASSET MANAGEMENT LLC's linked filing trail.
Disclosed position value
Top 5
ACADIAN ASSET MANAGEMENT LLC
$28K
Virtu Financial LLC
$11K
RENAISSANCE TECHNOLOGIES LLC
$10K
CITADEL ADVISORS LLC
$7K
UBS Group AG
$5.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 7 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$28,000
105,039 shares
|
— | 31 Mar 2023 |
| Virtu Financial LLC |
13F
Company
|
—
denominator unverified
|
$11,000
39,427 shares
|
— | 31 Mar 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$10,000
34,500 shares
|
— | 31 Mar 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$7,018
24,410 shares
|
— | 31 Mar 2023 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$5,096
17,945 shares
|
— | 31 Mar 2023 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
—
denominator unverified
|
$4,398
15,506 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
4
Shares
146,558
Rows available
4
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
6
Q2 2023 holders
4
Holder diff
-2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|